Key result
Thymosin beta 4 sulfoxide inhibits actin polymerization approximately 20-times less than Thymosin beta 4, reflecting a 20-times lower affinity to actin under polymerizing conditions.
Effect estimate: 20-times lower affinity
Oxidation of the methionine residue in T beta 4 to its sulfoxide significantly reduces its ability to inhibit actin polymerization, suggesting a potential regulatory switch for filament formation.
Extends in vitro evidence for redox control of actin; no immediate clinical implications in cardiovascular disease.
Thymosin beta 4 (T beta 4), a peptide of 43 amino acids, binds to actin monomers and inhibits filament formation. In preparations of T beta 4 from bovine lung tissue, the peptide is accompanied by a derivative in which the methionine residue in position 6 is replaced by its sulfoxide. T beta 4 sulfoxide inhibits actin polymerization to an extent approximately 20-times less than T beta 4. While an equimolar amount of T beta 4 prevented actin polymerization almost completely, polymerization with the corresponding amount of the sulfoxide proceeded in a manner similar to that of pure actin, except for a slight retardation. We showed that the decrease in the inhibitory activity is reflected by a 20-times lower affinity to actin. Interestingly, under non-polymerizing conditions, the affinity of T beta 4 sulfoxide for actin is as high as that of T beta 4 (approximately 1 microM). In accordance with this, no differences were found between T beta 4 and the sulfoxide in cross-linking experiments with the monomer, where both forms of the peptide yielded similar amounts of a 47-kDa band representing conjugates of actin and beta-thymosin, as proved by Western-blotting analysis. Likewise, both, T beta 4 and the sulfoxide retarded the exchange of G-actin-bound nucleotide to similar extents. Although the sulfoxide is presumably a product of autoxidation, it is attractive to speculate that oxidation of the methionine residue in T beta 4 may represent a regulatory switch for starting filament formation in non-muscle cells.
No takes yet. Share an insight, caveat, or question.
Heintz et al. (1994) studied this question. Thymosin beta 4 sulfoxide vs. Thymosin beta 4 was evaluated on Actin polymerization inhibition and affinity to actin (20-times lower affinity). Thymosin beta 4 sulfoxide inhibits actin polymerization approximately 20-times less than Thymosin beta 4, reflecting a 20-times lower affinity to actin under polymerizing conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: